MENU

3 exciting small cap healthcare shares on my watchlist

One part of the market that I think has bright long-term growth prospects is the healthcare sector.

Because of this, I believe it could be well worth looking at some of the smaller companies in the sector that have the potential to grow meaningfully over the next decade.

Three which I think deserve a spot on your watchlist are as follows:

Ellex Medical Lasers Ltd (ASX: ELX)

Ellex Medical Lasers is a medical device company focused on the development, manufacture, and sale of lasers and diagnostic equipment for the treatment of eye diseases. The company’s performance has been a touch mixed over the last 18 months, but yesterday it revealed a return to form at its annual general meeting. For the first four months of FY 2018 sales have increased 27% to $24.7 million. A key driver of this growth was a 38% lift in the sales of its Ellex iTrack product in the United States.

Telix Pharmaceuticals Ltd (ASX: TLX)

Led by Dr Christian Behrenbruch, Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals. The company has been very busy this year with trials, collaborations, and acquisitions. All in all, I believe its hard work this year means the company is well-positioned to grow strongly over the long-term.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a healthcare technology company providing breast imaging analytics and analysis software. Its software has been growing its share of the U.S. breast screening market at an impressive rate and shows no signs of slowing. The good news is that with much of its breast imaging analytics data flowing to the cloud, it now has one of the biggest cross-vendor data sets in mammography. As well as using this data to help detect breast cancer early, it intends to leverage it to develop new products.

Top 3 ASX Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked…

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of The Motley Fool’s Top 3 Blue Chip Stocks for 2019.

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in a specially prepared FREE report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

See the 3 blue chip stocks

Motley Fool contributor James Mickleboro owns shares of TELIXPHARM DEF SET. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of Ellex Medical Lasers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.